BioCentury | Jan 29, 2020
Company News

Jan. 28 Company Quick Takes: Kite, Alkermes, Regeneron-Sanofi, Incyte, NantHealth-NantOmics, Sorrento, MicroCures, Paion-Mundipharma

...NantWorks-affiliated companies NantHealth Inc. (NASDAQ:NH) gained $0.74 (56%) to $2.05 Tuesday after it and fellow NantWorks-affiliate...
BioCentury | Sep 12, 2019
Distillery Therapeutics

Tumor-targeted serum albumin-chemotherapy conjugates for improved delivery to breast and colorectal cancers

...PD-1 eradicated established tumors, prolonged lifespan and induced resistance to tumor rechallenge. CytRx Corp. and NantWorks...
BioCentury | Apr 12, 2019
Company News

Sorrento sues NantWorks' Soon-Shiong over alleged 'catch and kill' scheme

...Sorrento filed two lawsuits against Patrick Soon-Shiong and companies under his NantWorks umbrella for allegedly buying...
...reaching the market. In 2015, Sorrento Therapeutics Inc. (NASDAQ:SRNE) sold its Igdrasol Inc. subsidiary to NantWorks...
...Soon-Shiong's Abraxis BioScience Inc., and Soon-Shiong became a shareholder in Celgene (see "Sorrento Rises on NantWorks...
BioCentury | Jan 11, 2019
Financial News

Celgene invested $30M in NantCell weeks before BMS bid

...the immuno-oncology subsidiary of NantWorks LLC (Los Angeles, Calif.). NantWorks LLC, Los Angeles, Calif. Chris Lieu Celgene Corp. NantWorks...
BioCentury | Jan 6, 2019
Financial News

Celgene invested $30M in NantCell weeks before BMS bid

...and urothelial carcinoma. NantCell is the immuno-oncology subsidiary of NantWorks LLC (Los Angeles, Calif.). Chris Lieu Celgene Corp. NantWorks...
BioCentury | Jul 10, 2018
Distillery Therapeutics

Cancer

...Next steps could include testing POU2F3 inhibition in animal models of POU2F3-expressing SCLC. Amgen Inc., NantWorks...
BioCentury | Jun 21, 2018
Product R&D

Tusk’s take on CD25

...activity towards effector T cells. Front runners among next-generation agents include Nektar Therapeutics’ NKTR-214 and NantWorks...
...York, N.Y. Genmab A/S (CSE:GEN; Pink:GMXAY), Copenhagen, Denmark Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. NantWorks...
BioCentury | Jun 9, 2018
Product Development

POC for cytokines

...Therapeutics’ NKTR-214 at the American Society of Clinical Oncology (ASCO) meeting and data published on NantWorks...
...IL-15 to IL-15RA keeps the needed receptor close at hand and improves the construct’s stability. NantWorks...
...enough effector cells,” he added. In a similar vein, Chairman and CEO Patrick Soon-Shiong said NantWorks...
BioCentury | Jul 7, 2017
Company News

NantWorks acquires Altor BioScience

...The NantCell immuno-oncology subsidiary of NantWorks LLC (Los Angeles, Calif.) will acquire Altor BioScience Corp. (Miramar...
...BioScience Corp. , Miramar, Fla. NantWorks LLC , Los Angeles, Calif. Business: Cancer Shannon Lehnbeuter ALT-803 Altor BioScience Corp. NantWorks...
BioCentury | Apr 21, 2017
Company News

NantWorks, Genos deal

...million in Genos. Genos declined to disclose details and NantOmics did not respond to inquiries. NantWorks...
...Los Angeles, Calif. Genos Research Inc. , San Francisco, Calif. Business: Diagnostic Julian Zhu Genos Research Inc. NantWorks...
Items per page:
1 - 10 of 63
BioCentury | Jan 29, 2020
Company News

Jan. 28 Company Quick Takes: Kite, Alkermes, Regeneron-Sanofi, Incyte, NantHealth-NantOmics, Sorrento, MicroCures, Paion-Mundipharma

...NantWorks-affiliated companies NantHealth Inc. (NASDAQ:NH) gained $0.74 (56%) to $2.05 Tuesday after it and fellow NantWorks-affiliate...
BioCentury | Sep 12, 2019
Distillery Therapeutics

Tumor-targeted serum albumin-chemotherapy conjugates for improved delivery to breast and colorectal cancers

...PD-1 eradicated established tumors, prolonged lifespan and induced resistance to tumor rechallenge. CytRx Corp. and NantWorks...
BioCentury | Apr 12, 2019
Company News

Sorrento sues NantWorks' Soon-Shiong over alleged 'catch and kill' scheme

...Sorrento filed two lawsuits against Patrick Soon-Shiong and companies under his NantWorks umbrella for allegedly buying...
...reaching the market. In 2015, Sorrento Therapeutics Inc. (NASDAQ:SRNE) sold its Igdrasol Inc. subsidiary to NantWorks...
...Soon-Shiong's Abraxis BioScience Inc., and Soon-Shiong became a shareholder in Celgene (see "Sorrento Rises on NantWorks...
BioCentury | Jan 11, 2019
Financial News

Celgene invested $30M in NantCell weeks before BMS bid

...the immuno-oncology subsidiary of NantWorks LLC (Los Angeles, Calif.). NantWorks LLC, Los Angeles, Calif. Chris Lieu Celgene Corp. NantWorks...
BioCentury | Jan 6, 2019
Financial News

Celgene invested $30M in NantCell weeks before BMS bid

...and urothelial carcinoma. NantCell is the immuno-oncology subsidiary of NantWorks LLC (Los Angeles, Calif.). Chris Lieu Celgene Corp. NantWorks...
BioCentury | Jul 10, 2018
Distillery Therapeutics

Cancer

...Next steps could include testing POU2F3 inhibition in animal models of POU2F3-expressing SCLC. Amgen Inc., NantWorks...
BioCentury | Jun 21, 2018
Product R&D

Tusk’s take on CD25

...activity towards effector T cells. Front runners among next-generation agents include Nektar Therapeutics’ NKTR-214 and NantWorks...
...York, N.Y. Genmab A/S (CSE:GEN; Pink:GMXAY), Copenhagen, Denmark Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. NantWorks...
BioCentury | Jun 9, 2018
Product Development

POC for cytokines

...Therapeutics’ NKTR-214 at the American Society of Clinical Oncology (ASCO) meeting and data published on NantWorks...
...IL-15 to IL-15RA keeps the needed receptor close at hand and improves the construct’s stability. NantWorks...
...enough effector cells,” he added. In a similar vein, Chairman and CEO Patrick Soon-Shiong said NantWorks...
BioCentury | Jul 7, 2017
Company News

NantWorks acquires Altor BioScience

...The NantCell immuno-oncology subsidiary of NantWorks LLC (Los Angeles, Calif.) will acquire Altor BioScience Corp. (Miramar...
...BioScience Corp. , Miramar, Fla. NantWorks LLC , Los Angeles, Calif. Business: Cancer Shannon Lehnbeuter ALT-803 Altor BioScience Corp. NantWorks...
BioCentury | Apr 21, 2017
Company News

NantWorks, Genos deal

...million in Genos. Genos declined to disclose details and NantOmics did not respond to inquiries. NantWorks...
...Los Angeles, Calif. Genos Research Inc. , San Francisco, Calif. Business: Diagnostic Julian Zhu Genos Research Inc. NantWorks...
Items per page:
1 - 10 of 63